Captodiame

NERVOUS SYSTEM

Key facts

Captodiame is a drug catalogued in DrugCentral. Recorded indications include Anxiety disorder.

• Indications: Anxiety disorder.
• ATC code: N05BB02 (Diphenylmethane derivatives).
• Molecular formula: C21H29NS2; molecular weight 359.59 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

• Anxiety disorder

ATC classification

ATC code	Therapeutic hierarchy
N05BB02	NERVOUS SYSTEM › PSYCHOLEPTICS › ANXIOLYTICS › Diphenylmethane derivatives

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Captodiame is on its molecule page.

• Molecular formula: C₂₁H₂₉NS₂
• Molecular weight: 359.59 g/mol
• CAS number: 486-17-9
• InChIKey: IZLPZXSZLLELBJ-UHFFFAOYSA-N
• PubChem CID: 10240

CCCCSC1=CC=C(C=C1)C(SCCN(C)C)C1=CC=CC=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Captodiame used for?

DrugCentral lists the following indications for Captodiame: Anxiety disorder.

What is the chemical formula of Captodiame?

Captodiame has the molecular formula C21H29NS2 and a molecular weight of 359.59 g/mol.

Sources

• DrugCentral drug card 483 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL2106143 — compound record and bioactivity
• PubChem CID 10240 — chemical identifiers
• DrugBank DB09014 — drug record
• FDA UNII H93K9455DD — substance identity

How this page is built: methodology · editorial policy & corrections.